Pulmonary embolism associated with combined oral contraceptives: Reporting incidences and potential risk factors for a fatal outcome

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 6, 2004, Pages 576-585

  Hedenmalm, Karin ^a,d   Samuelsson, Eva ^b   Spigset, Olav ^c  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d Box 26   (Sweden)

Author keywords

Combined oral contraceptives; Pulmonary embolism; Risk factors

Indexed keywords

ALLYLESTRENOL; CYPROTERONE ACETATE; DESOGESTREL; DROSPIRENONE; ETHINYLESTRADIOL; ETYNODIOL DIACETATE; GESTAGEN; LEVONORGESTREL; LYNESTRENOL; MEGESTROL ACETATE; MESTRANOL; NORETHISTERONE; NORETYNODREL; NORGESTIMATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; CALCULATION; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; FATALITY; HUMAN; INCIDENCE; LUNG EMBOLISM; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALFORMATION SYNDROME; MEDICAL RECORD; NAUSEA; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; THORAX PAIN; TIME SERIES ANALYSIS; VENOUS THROMBOEMBOLISM;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; INCIDENCE; MEDICAL RECORDS; NORWAY; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS;

EID: 2542541247     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.0533.x     Document Type: Article

References (22)

1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
2. Böttiger LE, Boman G, Eklund G, Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet 1980; 1: 1097-101.
3. Stolley PD, Tonascia JA, Tockman MS, Sartwell PE, Rutledge AH, Jacobs MP. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol 1975; 102: 197-208.
4. Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 1991; 133: 32-7.
5. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of a deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-6.
6. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002; 22: 201-10.
7. Odlind V, Milsom I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 2002; 81: 482-90.
8. Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 2001; 323: 131-4.
9. Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001; 358: 1427-9.
10. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-93.
11. Parkin L, Skegg DC, Wilson M, Herbison GP, Paul C. Oral contraceptives and fatal pulmonary embolism. Lancet 2000; 355: 2133-4.
12. Fotherby K. A metabolic assessment of different oral contraceptives. J Obstet Gynaecol 1983; 3: S77-S82.
13. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339: 93-104.
14. Kearon C. Diagnosis of pulmonary embolism. CMAJ 2003; 168: 183-94.
15. Turpie AG, Chin BS, Lip GY. Venous thromboembolism. pathophysiology, clinical features, and prevention. BMJ 2002; 325: 887-90.
16. Gorman WP, Davis KR, Donnelly R. ABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosis. BMJ 2000; 320: 1453-6.
17. Egermayer P. Obesity, oral contraceptives, and fatal pulmonary embolism. N Z Med J 2001; 114: 170-1.
18. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575-82.
19. Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. BMJ 1969; 2: 651-7.
20. Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae KD, Tyrer F et al. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol 2000; 49: 580-90.
21. Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998; 57: 291-301.
22. Hägg S, Spigset O. Antipsychotic-induced venous thromboembolism. A review of the evidence. CNS Drugs 2002; 16: 765-76.